|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 18, 2005
Molecular Oncology, Max-Planck-Institute of Biochemistry, Martinsried 82152
Corresponding Author: herme{at}biochem.mpg.de
In order to comprehensively identify proteins interacting with 14-3-3 in vivo, tandem affinity purification (TAP) and the multidimensional protein identification technology (MudPIT) were combined to characterize 117 proteins presumably associated with 14-3-3sigma in human cells. The majority of identified proteins contained one or several phosphorylatable 14-3-3 binding sites indicating a potential direct interaction with 14-3-3sigma. 25 proteins were not previously assigned to any function and were named SIP2-26 (for 14-3-3sigma-interacting-protein). Among the 92 interactors with known function were a number of proteins previously implicated in oncogenic signaling (APC, A-RAF, B-RAF, c-RAF) and cell cycle regulation (AJUBA, c-TAK, PTOV-1, WEE1). The largest functional classes comprised proteins involved in the regulation of cytoskeletal dynamics, polarity, adhesion, mitogenic signaling and motility. Accordingly, ectopic 14-3-3sigma expression prevented cellular migration in a wounding assay and enhanced MAP-kinase signaling. The functional diversity of the identified proteins indicates that induction of 14-3-3sigma could allow p53 to affect numerous processes in addition to the previously characterized inhibitory effect on G2/M progression. The data suggest that the cancer-specific loss of 14-3-3sigmaexpressionby epigenetic silencing or p53 mutations contributes to cancer formation by multiple routes.
Revised on March 18, 2005
Accepted on March 18, 2005
Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. M. Atkins, L. Thomas, R. T. Youker, M. J. Harriff, F. Pissani, H. You, and G. Thomas HIV-1 Nef Binds PACS-2 to Assemble a Multikinase Cascade That Triggers Major Histocompatibility Complex Class I (MHC-I) Down-regulation: ANALYSIS USING SHORT INTERFERING RNA AND KNOCK-OUT MICE J. Biol. Chem., April 25, 2008; 283(17): 11772 - 11784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding Mol. Biol. Cell, April 1, 2007; 18(4): 1167 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bridges and G. B. G. Moorhead 14-3-3 Proteins: A Number of Functions for a Numbered Protein Sci. Signal., August 9, 2005; 2005(296): re10 - re10. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |